News

April 10, 2014 — The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for an increased use of radio frequency (RF) ablation in the treatment of non-...

atrial fibrillation, LARIAT

Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique called the Lariat Suture Delivery Device to treat patients with atrial fibrillation who...

Biosense Webster Thermocool Smarttouch Catheter Atrial Fibrillation Ablation EP

The U.S. Food and Drug Administration (FDA) approved Biosense Webster Inc.’s Thermocool Smarttouch Catheter. The therapeutic catheter enables direct and real-time measurement of contact force...

Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke...

Ablation Systems Balloon Atrial Fibrillation Therapies EP Lab Apama Shifamed

Apama Medical is a privately held medical device company formed by Shifamed's medical incubator. It received Chinese notice of allowance for claims covering their low profile electrode assembly...

DECAFF MRI Atrial Fibrillation Therapies Ablation Systems EP Lab Clinical Study

A University of Utah-led study for treatment of patients with atrial fibrillation (A-fib) provides strong...

A clinical trial found that Xa inhibitor edoxaban met the primary efficacy endpoint of non-inferiority compared to warfarin for the prevention of stroke or systemic embolic events (SEE) in...

topera 3-d 3d mapping system firmap rhythmview EP lab mapping fibrillation

Topera Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest generation of its 3D Mapping System.

AtriCure Inc., an atrial fibrillation (AF) medical device provider, and Endoscopic Technologies Inc, doing...

Atrial fibrillation (AF), long considered the most common condition leading to an irregular heartbeat, is a growing and...

CSL Behring announced that Kcentra (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication — urgent reversal of acquired...

Watchman, LAA occluder, atrial fibrillation

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably Dec. 11 in a 13-1 vote that the benefits of the Watchman...

topera 3-d ep lab atrial fibrillation therapies mapping/imaging systems

Topera Inc. shared the results of an independent evaluation of its diagnostic system’s ability to improve atrial...

laa occluders structural heart atrial fibrillation atricure atriclip exclusion

AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in a clinical study of AtriCure’s...

cardiac diagnostics clinical trial s tudy atrial fibrillation therapies ep lab

Doctors have known for years that atrial fibrillation (AF) increases the risk for stroke, but now researchers...

LAA occluder, Watchman

According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will drive rapid growth in the market for...

Medtronic Inc. announced clinical trial results showing that heart failure patients treated with its AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (...

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and...

Carto 3, Biosense Webster, CartoUnivu

Nationwide data show that although only about 12 percent of X-ray exams are for interventional cardiology or electrophysiology (EP) procedures, nearly 50 percent of a patient’s lifetime radiation...

Nanostim, leadless pacemaker

There have been several advances in electrophysiology (EP) technologies this past year, many of which were highlighted during the Heart Rhythm Society (HRS) 2013 scientific sessions earlier this...

June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has developed a unique mechanical occlusion device called the TigerPaw System II....

New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and rotor modulation (FIRM) mapping to effectively target atrial fibrillation (AF) sources and...

Endosense, tacticath, contact force, electrophysiology

New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of contact force technology focused on improving the efficacy and safety of catheter...

nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the CONVERGE...

Thermocool Smarttouch, Biosense webster force sensing

Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool Smarttouch catheter and software module in the treatment of symptomatic, drug refractory, paroxysmal...

BioSense Webster eMARQable Clinical Study nMARQ System Atrial Fibrillation

Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study. ReMARQable will assess the safety and efficacy of the use of the nMARQ Pulmonary Vein...

The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major...

A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase the risk and...

Endosense TactiCath

Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the development of guidelines for target and minimum contact force (CF), as well as minimum...

iRhythm Technologies Inc. Clinical Study Holter Zio Patch AF Therapies

iRhythm Technologies Inc. announced clinical study findings showing that use of the Zio Patch resulted in a change in treatment strategy for nearly one-third of patients with paroxysmal atrial...

Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation

Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The data was supposed to be presented during the 2013 American College of...

March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the company’s Amplatzer cardiac plug (ACP) for the prevention of stroke.

Lumax 740 DX system, ICD

The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX system. The device is a first-in-class implantable cardiac defibrillator (ICD...

Top stories of 2012 in cardiology

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the...

Boston Scientific Blazer Open-Irrgated Catheter Atrial Fibrillation ZERO AF

The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer open-irrigated temperature ablation Catheter...

Philips BioSense Webster EP Navigator Boston Atrial Fibrillation Symposium

At the Boston Atrial Fibrillation (AF) Symposium 2013, Philips Healthcare introduced its latest innovations in advanced imaging integration for electrophysiologists, showcasing its new EP...

EPi-Sense Guilded Coagulation Device nContact VisiTrax

nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing...

AliveCor Heart Monitor Phone Atrial Fibrillation

The results of a recent study presented yesterday at the American Heart Association Scientific Sessions 2012 conference in Los Angeles showed that a high-quality single-lead ECG can be quickly and...

Biomedical Systems TruVue Wireless Ambulatory ECG Monitoring System

The U.S. Patent and Trademark Office has awarded Biomedical Systems U.S. Patent Number 8301236 for its TruVue Wireless Ambulatory ECG Monitoring System.  Biomedical Systems developed TruVue...

November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism, major bleeding, and mortality demonstrated with Eliquis compared to...

CoaguChek XS Plus System Point of Care Testing Blood Testing

The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments (CLIA)-waived status to the Roche CoaguChek XS Plus system. The point-of-care...

October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa (dabigatran), has been rapidly adopted into clinical practice, yet thus far has...

Pfizer Bristol-Myers Squibb Eliquis

October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the new drug application (NDA) resubmission...

September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial...

September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S. Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban...

September 11, 2012 — Since the previous consensus document was published in 2007, catheter and surgical ablation of atrial...

September 10, 2012 — Atrial fibrillation (AF) is a common complication of cardiac surgery, occurring in 10 to 40...

August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge two highly advanced technologies for...

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and target its ablation to greatly reduce procedure time and substantially improve...

Over the past decade there have been several advancements in prothrombin time (PT)/international normalized ration (INR) point-of-care testing (POCT) devices. This is usually performed at an...

July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug Administration (FDA) approval for the Watchman Left Atrial...

June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has...

June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) capsules prescribing information has been updated to affirm that "Pradaxa 150...

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...

May 24, 2012 -- nContact Inc., a provider of  epicardial ablation devices, announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...

A new electromapping technique can better visualize the rotor (similar to the eye of a hurricane) around which atrial fibrillation electrical activity rotates. Using this map, the...